chr15-33818652-C-G
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_ModerateBP6_ModerateBP7
The NM_001036.6(RYR3):c.10674C>G(p.Leu3558Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000013   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000014   (  0   hom.  ) 
Consequence
 RYR3
NM_001036.6 synonymous
NM_001036.6 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -2.25  
Publications
0 publications found 
Genes affected
 RYR3  (HGNC:10485):  (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011] 
RYR3 Gene-Disease associations (from GenCC):
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen, G2P
- congenital myopathyInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41). 
BP6
Variant 15-33818652-C-G is Benign according to our data. Variant chr15-33818652-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 531125.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=-2.25 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152218Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2
AN: 
152218
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000201  AC: 5AN: 249034 AF XY:  0.0000222   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
5
AN: 
249034
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000137  AC: 20AN: 1461626Hom.:  0  Cov.: 30 AF XY:  0.0000151  AC XY: 11AN XY: 727096 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
20
AN: 
1461626
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
11
AN XY: 
727096
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33476
American (AMR) 
 AF: 
AC: 
0
AN: 
44720
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86242
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53386
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
5758
European-Non Finnish (NFE) 
 AF: 
AC: 
18
AN: 
1111838
Other (OTH) 
 AF: 
AC: 
1
AN: 
60370
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.493 
Heterozygous variant carriers
 0 
 1 
 3 
 4 
 6 
 7 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000131  AC: 2AN: 152218Hom.:  0  Cov.: 32 AF XY:  0.0000269  AC XY: 2AN XY: 74358 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2
AN: 
152218
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
2
AN XY: 
74358
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41468
American (AMR) 
 AF: 
AC: 
0
AN: 
15286
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4828
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10622
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
68042
Other (OTH) 
 AF: 
AC: 
0
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.425 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Epileptic encephalopathy    Benign:1 
Jun 09, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.